Gene editing: beyond the hypeGenome editing is an exciting but still nascent field, and companies in the area face as many obstacles Share XGene editing: beyond the hypehttps://pharmaphorum.com/r-d/views-analysis-r-d/genome-editing-sangamo-beyond-the-hype/
Targeting Solid & Liquid Malignancies with the Same CARCell and Gene Therapy Share XTargeting Solid & Liquid Malignancies with the Same CARhttps://pharmaphorum.com/partner-content/targeting-solid-liquid-malignancies-with-the-same-car/
